Traditional MedicareCoverageHigh impact
Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
Medicare/CMS - LCD·Local Coverage Determination
Effective date
Jul 13, 2026
We identified it
Jul 28, 2026
Summary
INSUFFICIENT DATA: The policy title indicates this is a Local Coverage Determination (LCD L33394) from WellPoint Federal regarding coverage of drugs and biologicals for both label and off-label uses, effective 7/13/2026. However, the actual policy content/details were not provided in the source material, making it impossible to determine specific coverage changes, affected drug codes, or actionable billing requirements.
Action Required
URGENT - By 7/13/2026: Billing team must obtain the complete policy text from the CMS Medicare Coverage Database (https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=33394&ver=55) or contact WellPoint Federal directly for the full LCD L33394 details. Once received, review for: (1) specific HCPCS drug/biologic codes affected, (2) coverage criteria for off-label uses, (3) prior authorization requirements, (4) documentation requirements for medical necessity. Update billing software, encounter forms, and provider guidelines accordingly. Claims submitted without compliance to new coverage rules will be denied.